Opinion: how patients have benefited from mouse models of acute promyelocytic leukaemia.
about
Mechanisms of Microbe-Host Interaction in Crohn's Disease: Dysbiosis vs. Pathobiont SelectionThe cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodiesHow animal models of leukaemias have already benefited patientsValproic acid induces differentiation and transient tumor regression, but spares leukemia-initiating activity in mouse models of APL.Aberrant chromatin remodeling by retinoic acid receptor alpha fusion proteins assessed at the single-cell levelTarget for cancer therapy: proliferating cells or stem cells.ASB2 targets filamins A and B to proteasomal degradation.Synergistic targeted therapy for acute promyelocytic leukaemia: a model of translational research in human cancer.Chimeric antigen receptor T cells for the treatment of cancer and the future of preclinical models for predicting their toxicities.Finding a needle in a haystack: whole genome sequencing and mutation discovery in murine models.Sumoylation and Its Contribution to Cancer.[Malignancy potential of precursor lesions: determination using molecular markers].
P2860
Q26774688-A9973E9C-A844-473D-B7B4-E4D5903E75D7Q26853348-51685A9B-B17B-4986-8E38-450FD121A0C2Q26997702-C34DD727-9055-404E-AAA7-9FEF8FCE92D0Q34254302-2645B0E9-7293-41CB-9E68-E502926917F1Q36017077-4BA9E998-EB4E-45C9-A9C9-59508240763EQ36343524-36E1B421-AE86-4BCD-B694-6FF1AC305D5DQ37003539-B366E43F-D2DC-49F7-A0A3-DCB34B6C5727Q38522309-C814136B-D5E6-4FA7-AC15-243400FD7797Q38666256-1AE8C3C9-4027-475A-A5E8-4305983514A1Q41908857-D36FC8B3-848B-4E16-8BB9-A8FA99D01A36Q51137572-4D2EA06F-FC14-4702-A8BA-58E7B8583D73Q53218333-B7C3D59B-DF3F-43A4-A1C8-EA0F5F83AD58
P2860
Opinion: how patients have benefited from mouse models of acute promyelocytic leukaemia.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Opinion: how patients have benefited from mouse models of acute promyelocytic leukaemia.
@en
Opinion: how patients have benefited from mouse models of acute promyelocytic leukaemia.
@nl
type
label
Opinion: how patients have benefited from mouse models of acute promyelocytic leukaemia.
@en
Opinion: how patients have benefited from mouse models of acute promyelocytic leukaemia.
@nl
prefLabel
Opinion: how patients have benefited from mouse models of acute promyelocytic leukaemia.
@en
Opinion: how patients have benefited from mouse models of acute promyelocytic leukaemia.
@nl
P2093
P2860
P356
P1476
Opinion: how patients have benefited from mouse models of acute promyelocytic leukaemia.
@en
P2093
Hugues de Thé
Scott Kogan
Valérie Lallemand-Breitenbach
P2860
P2888
P304
P356
10.1038/NRC1719
P407
P577
2005-10-01T00:00:00Z